Obesity drugs would be covered by Medicare and Medicaid under Biden administration proposal
About 7 million people enrolled in Medicare and Medicaid would gain access to weight-loss drugs like Ozempic, Wegovy, Zepbound and Mounjaro, which are not covered by these federal…
